Skip to main content
Equibles

VANGUARD ASSET MANAGEMENT, Ltd

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1680208 London, EC4N 8AF, X0
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,022,786
+$421,153 QoQ
Shares Held
56,948
+31.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 207 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VANGUARD ASSET MANAGEMENT, Ltd holds $174,411,094 across 30 Drug Manufacturers - Specialty & Generic names. AMLX ranks #21 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 833,504 $59,895,597
2 VTRS
Viatris Inc
 1,128,163 $17,915,228
3 TEVA
Teva Pharmaceutical Industries Ltd
 425,294 $14,408,960
4 ELAN
Elanco Animal Health Inc
 477,550 $11,752,505
5 UTHR
UNITED THERAPEUTICS Corp
 21,502 $11,650,428
6 NBIX
Neurocrine Biosciences Inc
 51,826 $8,734,754
7 ALKS
Alkermes plc.
 157,759 $8,266,571
8 HIMS
Hims & Hers Health, Inc.
 196,860 $6,825,136

All Filings in AMLX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,022,786 56,948
2026-03-31 $601,633 43,283